1. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med. 2001; 344:732–738.
Article
2. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004; 28(9):1193–1203.
Article
3. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002; 359(9315):1403–1404.
Article
4. Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005; 36(7):710–717.
Article
5. Lee KK, Cho HP, Lee YM, Park JH. A case of immunoglobulin G4-related sialadenitis and dacryoadenitis. Korean J Otorhinolaryngol-Head Neck Surg. 2013; 56(7):444–447.
Article
6. Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner’s tumor). Am J Surg Pathol. 2005; 29(6):783–791.
Article
7. Vandjelovic ND, Humphreys IM. Immunoglobulin G4-related sclerosing disease of the paranasal sinuses: A case report and literature review. Allergy Rhinol (Providence). 2016; 7(2):85–89.
Article
8. Lee JR, Lee BJ, Chung YS. Three Cases of IgG4-Related Sclerosing Disease in Nasal Cavity. J Rhinol. 2016; 23(1):44–48.
Article
9. Moteki H, Yasuo M, Hamano H, Uehara T, Usami S. IgG4 related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol. 2011; 131(5):518–526.
Article
10. Ishida M, Hotta M, Kushima R, Shibayama M, Shimizu T, Okabe H. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int. 2009; 59(9):670–675.
Article
11. Alt JA, Whitaker GT, Allan RW, Vaysberg M. Locally destructive skull base lesion: IgG4-related sclerosing disease. Allergy Rhinol (Providence). 2012; 3(1):e41–e45.
Article
12. Takano K, Yamamoto M, Takahashi H, Himi T. Recent advances in knowledge regarding the head and neck manifestations of IgG4-related disease. Auris Nasus Larynx. 2017; 44(1):7–17.
Article
13. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015; 74:14–18.
Article
14. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25:1181–1192.
Article
15. Khosroshahi A, Bloch DB, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010; 62:1755–1762.
Article
16. Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008; 32(8):1159–1167.
Article